WO2003100016A3 - Molecules de modification et de maintenance de proteines - Google Patents

Molecules de modification et de maintenance de proteines Download PDF

Info

Publication number
WO2003100016A3
WO2003100016A3 PCT/US2003/016498 US0316498W WO03100016A3 WO 2003100016 A3 WO2003100016 A3 WO 2003100016A3 US 0316498 W US0316498 W US 0316498W WO 03100016 A3 WO03100016 A3 WO 03100016A3
Authority
WO
WIPO (PCT)
Prior art keywords
pmmm
protein modification
maintenance molecules
molecules
maintenance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2003/016498
Other languages
English (en)
Other versions
WO2003100016A2 (fr
Inventor
Reena Khare
Sean A Bulloch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Corp filed Critical Incyte Corp
Priority to AU2003239871A priority Critical patent/AU2003239871A1/en
Publication of WO2003100016A2 publication Critical patent/WO2003100016A2/fr
Publication of WO2003100016A3 publication Critical patent/WO2003100016A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne, dans divers modes de réalisation, des molécules de modification et de maintenance de protéines humaines (PMMM) et des polynucléotides identifiant et codant pour les PMMM. Les modes de réalisation de l'invention concernent également des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes, et des antagonistes. D'autres modes de réalisation de l'invention concernent des méthodes de diagnostic, de traitement ou de prévention des troubles associés à l'expression aberrante des PMMM.
PCT/US2003/016498 2002-05-22 2003-05-22 Molecules de modification et de maintenance de proteines Ceased WO2003100016A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003239871A AU2003239871A1 (en) 2002-05-22 2003-05-22 Protein modification and maintenance molecules

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US38349102P 2002-05-22 2002-05-22
US60/383,491 2002-05-22
US39137802P 2002-06-24 2002-06-24
US60/391,378 2002-06-24
US39792102P 2002-07-22 2002-07-22
US60/397,921 2002-07-22

Publications (2)

Publication Number Publication Date
WO2003100016A2 WO2003100016A2 (fr) 2003-12-04
WO2003100016A3 true WO2003100016A3 (fr) 2004-04-01

Family

ID=29587699

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/016498 Ceased WO2003100016A2 (fr) 2002-05-22 2003-05-22 Molecules de modification et de maintenance de proteines

Country Status (2)

Country Link
AU (1) AU2003239871A1 (fr)
WO (1) WO2003100016A2 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8927700B2 (en) 2009-08-21 2015-01-06 Gilead Biologics, Inc. Catalytic domains from lysyl oxidase and LOXL2
US9107935B2 (en) 2009-01-06 2015-08-18 Gilead Biologics, Inc. Chemotherapeutic methods and compositions
US9176139B2 (en) 2007-08-02 2015-11-03 Gilead Biologics, Inc. LOX and LOXL2 inhibitors and uses thereof

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009525319A (ja) 2006-02-02 2009-07-09 ライナット ニューロサイエンス コーポレイション ｔｒｋＢアンタゴニストを投与することにより肥満を治療する方法
EP3042666A1 (fr) * 2015-01-06 2016-07-13 Rheinisch-Westfälische Technische Hochschule Aachen Fragments d'ITIH5 pour le traitement du cancer

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999057140A2 (fr) * 1998-05-07 1999-11-11 Incyte Pharmaceuticals, Inc. Precurseur de chaine lourde d'inhibiteur de protease associe a la croissance
EP1074617A2 (fr) * 1999-07-29 2001-02-07 Helix Research Institute Amorces pour la synthèse de cADN de pleine longueur et leur utilisation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999057140A2 (fr) * 1998-05-07 1999-11-11 Incyte Pharmaceuticals, Inc. Precurseur de chaine lourde d'inhibiteur de protease associe a la croissance
US20020099178A1 (en) * 1998-05-07 2002-07-25 Incyte Pharmaceuticals, Inc. Growth-associated protease inhibitor heavy chain precursor
EP1074617A2 (fr) * 1999-07-29 2001-02-07 Helix Research Institute Amorces pour la synthèse de cADN de pleine longueur et leur utilisation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE PROTEIN [online] 15 February 2000 (2000-02-15), HILLMAN J.L. ET AL., XP002973777, Database accession no. (AAY32169) *
DATABASE PROTEIN [online] 26 June 2001 (2001-06-26), OTA T. ET AL., XP002973778, Database accession no. (AAB95694) *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9176139B2 (en) 2007-08-02 2015-11-03 Gilead Biologics, Inc. LOX and LOXL2 inhibitors and uses thereof
US9107935B2 (en) 2009-01-06 2015-08-18 Gilead Biologics, Inc. Chemotherapeutic methods and compositions
US9289447B2 (en) 2009-01-06 2016-03-22 Gilead Biologics, Inc. Chemotherapeutic methods and compositions
US8927700B2 (en) 2009-08-21 2015-01-06 Gilead Biologics, Inc. Catalytic domains from lysyl oxidase and LOXL2

Also Published As

Publication number Publication date
WO2003100016A2 (fr) 2003-12-04
AU2003239871A8 (en) 2003-12-12
AU2003239871A1 (en) 2003-12-12

Similar Documents

Publication Publication Date Title
WO2002046383A3 (fr) Molecules de modification et de maintenance proteiques
WO2003052075A3 (fr) Enzymes
WO2002063005A3 (fr) Molecules associees a des lipides
WO2002002603A3 (fr) Molecules de modification et de maintenance de proteines
WO2003042357A3 (fr) Enzymes
WO2004044165A3 (fr) Proteines associees aux lipides
WO2004053068A3 (fr) Molecules de modification et de maintenance de proteines
WO2002097060A3 (fr) Proteines associees aux carbohydrates
WO2004009797A3 (fr) Molecules de modification et d'entretien de proteines
WO2003063688A3 (fr) Molecules de modification et d'entretien de proteines
WO2002060942A3 (fr) Molecules de modification et de maintenance proteiques
WO2003062391A3 (fr) Proteines structurelle associees au cytosquelette
WO2003076586A3 (fr) Proteines associees a des acides nucleiques
WO2003083084A3 (fr) Molecules de modification et d'entretien de proteines
WO2003031939A3 (fr) Molecules proteiques de modification et d'entretien
WO2003100016A3 (fr) Molecules de modification et de maintenance de proteines
WO2004003162A3 (fr) Enzymes
WO2002066646A3 (fr) Proteines associees a la neurotransmission
WO2003072729A3 (fr) Enzymes
WO2003025150A3 (fr) Molecules associees a des lipides
WO2003083082A3 (fr) Enzymes
WO2003093439A3 (fr) Enzymes
WO2003025131A3 (fr) Molecules de maintenance et de modification de proteines
WO2004033636A3 (fr) Molecules de modification et de maintien de proteines
WO2004022705A3 (fr) Proteines associees a la neurotransmission

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP